Cargando…
Successful Treatment of Persistent 5-Nitroimidazole–Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid
We describe a case of persistent 5-nitroimidazole–resistant trichomoniasis cured after 14 days of oral secnidazole and intravaginal boric acid. Secnidazole may be an important treatment option for resistant trichomoniasis, particularly in women who fail other regimens, including higher doses of oral...
Autores principales: | McNeil, Candice J., Williamson, John C., Muzny, Christina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010696/ https://www.ncbi.nlm.nih.gov/pubmed/36730040 http://dx.doi.org/10.1097/OLQ.0000000000001741 |
Ejemplares similares
-
Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data
por: Muzny, Christina A, et al.
Publicado: (2023) -
Candida lusitaniae as an Unusual Cause of Recurrent Vaginitis
and its Successful Treatment With Intravaginal Boric Acid
por: Silverman, Neil S., et al.
Publicado: (2001) -
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study
por: Muzny, Christina A, et al.
Publicado: (2021) -
In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis
por: Pentikis, Helen S., et al.
Publicado: (2020) -
Trichomoniasis: An update
por: Preethi, V, et al.
Publicado: (2011)